Strides’ Bangalore facility gets EIR from USFDA
The company’s flagship facility was inspected by the USFDA between December 5 and 9, 2022, and a form 483 listing three…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Strides Pharma Science
Strides Pharma recalls six lakh bottles of Losartan Potassium tablets in US
The affected lot of tables, in strengths of 25 mg, 50mg and 100 mg, have been manufactured by Vivimed Life Sciences
Strides Pharma unit gets US FDA approval for generic product
The company's product, which reduces inflammation and other symptoms of gout, is therapeutically equivalent to Takeda…
Strides Pharma Science to acquire Endo’s manufacturing facility in US
Strides said the facility at Chestnut Ridge, New York has an annual capacity of two billion units across semi-solids, liquids and…
Strides announces completion of EU GMP inspection at Puducherry facility
The company has now received the renewed GMP certificate thereby confirming the successful closure of the inspection
Ennaid Therapeutics partners with Strides to produce oral COVID‐19 tablet
Ennaid is ready to seek emergency authorisation from the FDA in the US as well as approval for compassionate use in India
Strides, TLC collaborate to launch black fungus drug in India
The CDSCO has approved TLC's new drug application (NDA) of Amphotericin B Liposome for Injection 50 mg in India for immediate…
Strides gets USFDA approval for Potassium Chloride for Oral Solution
Potassium Chloride Oral Solution is indicated for the treatment and prophylaxis of hypokalemia
Strides gets USFDA nod for Ibuprofen OTC Oral Suspension
Approval to strengthen company’s private label portfolio for the US market
Strides get USFDA nod for Ursodiol capsules
Ursodiol capsules are indicated for the treatment of patients with Primary Biliary Cirrhosis (PBC)